Table 2.
Summary of Clinical Presentations of NSAID Hypersensitivity in Preschool Children
| References | |
|---|---|
| Nonspecific, cross-reactive, COX inhibitor related | |
| ASA-exacerbated respiratory disease (AERD) | [9-12,32] |
| Angioedema/urticaria in children with chronic urticaria | [33-37] |
| Angioedema/urticaria in children without chronic urticaria | [15,38-40] |
| Mixed reactions (angioedema/urticaria and acute respiratory symptoms, bronchospasm) | [15,41] |
| The most common clinical manifestation of NSAID hypersensitivity at this age is facial angioedema with or without generalized urticaria | [13,15] |
| Drug-specific, immune-mediated reactions | |
| Immediate single drug-mediated urticaria/angioedema | [38,42] |
| Delayed-type hypersensitivity reactions (eg, fixed drug eruptions and toxic epidermal necrolysis) | [38,43-46] |
| No publications of ASA-/NSAID-induced aseptic meningitis or hypersensitivity pneumonitis were identified |
ASA = acetylsalicylic acid; COX = cyclooxygenase; NSAID = nonsteroidal anti-inflammatory drug.